M. Weiler

发表

Correlations Between rCBF and Symptoms in Two Independent Cohorts of Drug-Free Patients with Schizophrenia

H. Holcomb, R. McMahon, C. Tamminga, 2006, Neuropsychopharmacology.

Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia

H. Holcomb, C. Tamminga, A. Lahti, 2009, Neuropsychopharmacology.

Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine

P. O’Donnell, R. Buchanan, A. Lahti, 2010, Neuropsychopharmacology.

Interpretation of Negative Transference in Nonanalytic Settings

M. Weiler, 1988, International journal of psychiatry in medicine.

Affective Disorders and Borderline Personality

M. Weiler, H. Lahmeyer, F. Gaviria, 1985 .

Explorations in the Relationship of Dream Sleep to Schizophrenia Using Positron Emisson Tomography

M. Buchsbaum, W. Bunney, J. Gillin, 1990, Neuropsychobiology.

Nomifensine treatment of bulimia: Results of an open trial

M. Weiler, V. Raskin, T. Jobe, 1987 .

Time course of RCBF changes with haloperidol and olanzapine over a six week treatment period

C. Tamminga, A. Lahti, M. Weiler, 2003, Schizophrenia Research.

Effects of Ketamine in Normal and Schizophrenic Volunteers

C. Tamminga, A. Lahti, M. Weiler, 2001, Neuropsychopharmacology.

Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia

C. Tamminga, A. Lahti, A. Carlsson, 1998, Biological Psychiatry.

Long-term outcome of patients who receive ketamine during research

C. Tamminga, A. Lahti, M. Weiler, 2001, Biological Psychiatry.

EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder

G. Pandey, M. Weiler, E. Altman, 1988, Psychiatry Research.

Insight and symptom change in schizophrenia and other disorders

M. Weiler, M. Fleisher, D. McArthur-Campbell, 2000, Schizophrenia Research.

Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia

C. Tamminga, A. Carlsson, A. Lahti, 1998, Journal of Neural Transmission.

Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task.

H. Holcomb, C. Tamminga, W. Carpenter, 2001, The American journal of psychiatry.

Changing cognitive functioning in rehabilitation of schizophrenia

W. Spaulding, M. Weiler, D. Storzbach, 1994, Acta psychiatrica Scandinavica. Supplementum.

Antipsychotic Drugs Alter Functional Connectivity between the Medial Frontal Cortex, Hippocampus, and Nucleus Accumbens as Measured by H215O PET

Mark S. Bolding, H. Holcomb, A. Lahti, 2012, Front. Psychiatry.

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol

Carol A Tamminga, H. Holcomb, C. Tamminga, 2003, Biological Psychiatry.

Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex

H. Holcomb, C. Tamminga, A. Lahti, 2004, Neuropsychopharmacology.

Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS Dynamically

Carol A. Tamminga, Henry H. Holcomb, H. Holcomb, 2001, Neuropsychopharmacology.

Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia.

C. Tamminga, A. Lahti, G. Thaker, 2002, The American journal of psychiatry.

Associated diagnoses (comorbidity) in patients with borderline personality disorder.

M. Gaviria, M. Weiler, E. Altman, 1990, Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa.

The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers

A. Lahti, T. Blaxton, M. Weiler, 2005, Psychopharmacology.

Subtle effects of ketamine on memory when administered following stimulus presentation

C. Tamminga, A. Lahti, T. Blaxton, 2005, Psychopharmacology.

Ketamine Effects on Eye Movements

C. Tamminga, A. Lahti, G. Thaker, 2000, Neuropsychopharmacology.

Facial emotional expression in reaction to social exclusion in borderline personality disorder

M. Stopsack, B. Renneberg, M. Weiler, 2011, Psychological Medicine.

Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task.

D R Medoff, H. Holcomb, C. Tamminga, 2000, The American journal of psychiatry.

Neuroleptic Treatment of Schizophrenic Patients: How Do Haloperidol and Clozapine Normalize Brain Blood Flow Patterns Associated with a Difficult Tone Recognition Task?

H. Holcomb, C. Tamminga, A. Lahti, 1999 .

Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia

Carol A. Tamminga, Henry H. Holcomb, H. Holcomb, 2005, Psychiatry Research: Neuroimaging.

Studies with Dark Avoidance and Scotophobin

M. Weiler, H. N. Guttman, G. Matwyshyn, 1973 .

Effects of cognitive treatment in psychiatric rehabilitation.

W. Spaulding, M. Weiler, D. Reed, 1999, Schizophrenia bulletin.

Psychiatric correlates of rhythmic midtemporal discharges and 6/sec spike and wave complexes

J. R. Hughes, N. Boutros, M. Weiler, 1986, Biological Psychiatry.